18/10/19 -"We have raised our EBITDA expectations for Refinitiv due to higher cost synergies. Initially, we had factored in synergies of $450m by the end of 2020 (run rate) but we have now increased this to ..."
Pages
50
Language
English
Published on
18/10/19
You may also be interested by these reports :
19/04/24
Pluxee has released its first HY results post the IPO. The recurring financial indicators were stronger than anticipated, while the net profit ...
19/04/24
Investor has delivered a remarkable start to the year through impressive performances in all segments, driving a 10% increase in its NAV – ...
18/04/24
EdenRed’s Q1 2024 update was ahead of the consensus and our estimates. Organic growth increased by 16.9% on a lfl basis, driven by growth across all ...
18/04/24
Kinnevik released lacklustre results as its growth-oriented portfolio continued to suffer in this high interest rate environment. However, the new ...